MARÍA DOLORES
CABALLERO BARRIGÓN
Forscherin in der Zeit 1998-2022
Dokuz Eylül University
Esmirna, TurquíaPublikationen in Zusammenarbeit mit Forschern von Dokuz Eylül University (2)
2019
-
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
The Lancet Haematology, Vol. 6, Núm. 2, pp. e67-e78